Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kazdal

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
Genes, Chromosomes & Cancer|May 25, 2016
Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer-A survey across 822 routine diagnostic casesNicole Pfarr, Roland Penzel, Frederick Klauschen, et al.
Cold Spring Harbor Molecular Case Studies|October 7, 2022
Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case reportChristiane Wiedemann, Daniel Kazdal, Jelena Cvetkovic, et al.
Proteomics. Clinical Applications|September 15, 2018
Digital PCR After MALDI-Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary AdenocarcinomaDaniel Kazdal, Rémi Longuespée, Steffen Dietz, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 15, 2024
The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancerSarah Richtmann, Sebastian Marwitz, Thomas Muley, et al.
Proteomics. Clinical Applications|February 1, 2020
Microproteomics and Immunohistochemistry Reveal Differences in Aldo-Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's DiseaseKarim Arafah, Mark Kriegsmann, Marcus Renner, et al.
Frontiers in Oncology|July 26, 2021
Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung CarcinomaDavid Fisch, Farastuk Bozorgmehr, Daniel Kazdal, et al.
Pathologie (Heidelberg, Germany)|December 4, 2023
Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathologyAndy Kahles, Hannah Goldschmid, Anna-Lena Volckmar, et al.
Translational Oncology|June 16, 2023
Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)Michael Menzel, Volker Endris, Constantin Schwab, et al.
German Medical Science : GMS E-Journal|November 19, 2024
Pathology in the legal framework of European and German medical device law: Operation, use and in-house manufacture of in vitro diagnostic medical devicesAndy Kahles, Hannah Goldschmid, Anna-Lena Volckmar, et al.
Pathologie (Heidelberg, Germany)|October 4, 2023
[Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology]Andy Kahles, Hannah Goldschmid, Anna-Lena Volckmar, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Genes, Chromosomes & Cancer|May 25, 2016
Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer-A survey across 822 routine diagnostic casesNicole Pfarr, Roland Penzel, Frederick Klauschen, et al.
Cold Spring Harbor Molecular Case Studies|October 7, 2022
Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case reportChristiane Wiedemann, Daniel Kazdal, Jelena Cvetkovic, et al.
Proteomics. Clinical Applications|September 15, 2018
Digital PCR After MALDI-Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary AdenocarcinomaDaniel Kazdal, Rémi Longuespée, Steffen Dietz, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 15, 2024
The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancerSarah Richtmann, Sebastian Marwitz, Thomas Muley, et al.
Proteomics. Clinical Applications|February 1, 2020
Microproteomics and Immunohistochemistry Reveal Differences in Aldo-Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's DiseaseKarim Arafah, Mark Kriegsmann, Marcus Renner, et al.
Frontiers in Oncology|July 26, 2021
Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung CarcinomaDavid Fisch, Farastuk Bozorgmehr, Daniel Kazdal, et al.
Pathologie (Heidelberg, Germany)|December 4, 2023
Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathologyAndy Kahles, Hannah Goldschmid, Anna-Lena Volckmar, et al.
Translational Oncology|June 16, 2023
Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD)Michael Menzel, Volker Endris, Constantin Schwab, et al.
German Medical Science : GMS E-Journal|November 19, 2024
Pathology in the legal framework of European and German medical device law: Operation, use and in-house manufacture of in vitro diagnostic medical devicesAndy Kahles, Hannah Goldschmid, Anna-Lena Volckmar, et al.
Pathologie (Heidelberg, Germany)|October 4, 2023
[Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology]Andy Kahles, Hannah Goldschmid, Anna-Lena Volckmar, et al.
Pageof 12